Conditions: Breast Cancer
Keywords: Postmenopausal Women
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 40
Healthy volunteers: no

Brief summary:
The purpose of this trial is to evaluate time to progression in women with hormone responsive advanced breast cancer treated with a combination of exemestane and fulvestrant.

Detailed description:

Arms:
arm 1: Combination of daily exemestane 25 mg with monthly 250 mg Fulvestrant injection

Interventions: intervention 1: Exemestane intervention 2: Fulvestrant
Intervention descriptions: intervention 1: 25 mg orally per day intervention 2: 250 mg IM starting on Day 8 and then every 28 days.

Protocol document: